Bayer Bayer

View of the logo of the chemical company Bayer AG on Müllerstrasse. (Image archive). Photo: Jörg Carstensen / dpa

Source: dpa-infocom GmbH

Bayer may have won the controversy over the herbicide glyphosate. The chemical company hoped to get relief from the US Supreme Court ruling.

S.Bernardino / Leverkusen (DPA) – Bayer has won another lawsuit in the United States alleging that glyphosate-containing herbicides pose cancer risks.

Arbitration in San Bernardino, California, rejected the plaintiff’s claim that the use of the herbicide Roundup caused Hodgkin’s non – lymphoma.

Basic negotiations are pending

More important than the success of the case, however, was the decision of the U.S. Supreme Court in a preliminary hearing on the glyphosate controversy early next week. Bayer took over the problems of the toxic round plant containing glyphosate by acquiring the American seed company Monsanto in 2018.

A Bayer spokesman spoke on Friday about another “positive development of the glyphosate case.” Part of the plan is to bring cases to court “if the plaintiff’s attorneys make unreasonable claims.” However, the plaintiff’s attorney stated that the failure was due to technical circumstances because the process was conducted online by Zoom. Declared he wished to appeal.

Bayer had already won another lawsuit in October. At the time, an arbitral tribunal in Los Angeles found that Hodgkin’s use of the round was not for a boy with non-lymphoma.

The solution package solves many cases

Basically, the panel has already settled several U.S. cases as part of a large-scale settlement worth billions. Bayer set aside about eleven billion dollars for this. “Of the approximately 125,000 cases mentioned in the annual report, there are approximately 98,000 cases, including cases that did not meet the comparative criteria,” Bayer wrote in his latest quarterly report. The figures are for October 22. Bayer continues to emphasize the protection of glyphosate when used properly.

See also  Fastest third of the lap: Gerber only needs 66 minutes

The U.S. Supreme Court is now debating whether to admit one of the lost cases to trial. The judges wanted to discuss this on Friday, after which they would announce their decision on Monday.

Bayer before release

In his application to the Supreme Court, Bayer argues with the principle that federal law violates the law of individual states. As a result, the panel believes there can be no claims for damages under national law if false cancer risk warnings conflict with federal law. The responsible federal authority banned such a warning.

If the case is heard and the Supreme Court rules in favor of Bayer, it will be excused. The Leverkusen-based company hopes this will basically end the glyphosate controversy.

© dpa-infocom, dpa: 211210-99-326009 / 3


Please enter your comment!
Please enter your name here